Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development

Yarí E. Marín, Suzie Chen

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Melanoma is the aberrant proliferation of melanocytes, the cells in the skin responsible for pigment production. In the United States the current lifetime risk of melanoma development is 1 in 57 in males and 1 in 81 in females [1]. In its early stages melanoma can be surgically removed with great success; however, advanced stages of melanoma have a high mortality rate due to the lack of responsiveness to currently available therapies. The development of animal models to be used in the studies of melanoma will provide the means for developing improved and targeted treatments for this disease. This review focuses on the recent report of a mouse melanoma model, TG-3, which has implicated the ectopic expression of the metabotropic glutamate receptor 1 (Grm1), a G protein coupled receptor (GPCR), in melanomagenesis and metastasis [2]. The involvement of other GPCRs in cellular transformation, particularly GPCRs in melanoma biology, and signaling of Grm1 are also discussed.

Original languageEnglish (US)
Pages (from-to)735-749
Number of pages15
JournalJournal of Molecular Medicine
Issue number11
StatePublished - Nov 2004

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)


  • G protein coupled receptors
  • Glutamate receptors
  • Melanoma
  • Transformation
  • Transgenic models

Fingerprint Dive into the research topics of 'Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development'. Together they form a unique fingerprint.

Cite this